Clinical application: one powerful engine, many critical indications

Lead programme: detect sepsis before it kills. 

In acute clinical settings, every minute without appropriate treatment drastically reduces survival rates. Sepsis diagnostics demand extreme speed and high accuracy.

We are currently advancing the proof-of-concept for a rapid sepsis assay that identifies organisms directly from 10 ml whole blood without culture. 

Genetic antimicrobial resistance (AMR) profiling: providing genetic insights into resistance mechanisms to guide immediate, targeted antibiotic therapy.

One-hour turnaround: analyse 200 nucleic acid biomarkers to actionable data within the critical "golden hour" of patient admission.

Pipeline: oncology and precision medicine

Our immediate focus are the diagnostic bottlenecks in sepsis. Our underlying technology is a versatile biomarker detection engine with the ability to rapidly profile highly multiplexed RNA and DNA panels from low-input samples. We are actively exploring a pipeline of future indications in the following areas - reach out if interested! 

• Oncology biomarker profiling & cancer staging 
• Rapid liquid biopsy 
• "Real-time" monitoring of targeted therapies & minimal residual disease 
• Relapse monitoring 

You can find out more about our pipeline here.